Nifty

:

26142.10

Sensex

:

85408.70

-35.05 (-0.13%)
-116.14 (-0.14%)

Login

Nifty
Sensex

:
:

26142.10
85408.70

-35.05 (-0.13%)
-116.14 (-0.14%)

Nectar Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

32/99

BSE: 532649 | NSE: NECLIFE

Watchlist

NSE BSE

21.14

24-Dec-2025

Open
High
Low
Previous Close

21.14
21.14
21.14
22.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

64618
1366024.52
41.35
13.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

475.21
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

928.13
N/A
0.70

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.03
1.59
3.10

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
9.19
67.52

P:E (Median)

8 Years
5 Years
3 Years

7.02
-
28.89

P:BV (Average)

8 Years
5 Years
3 Years

0.51
0.56
0.57

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.79
7.58
6.10

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 5.71 5.73 -0.35% 280.67 359.30 -21.88% 430.69 441.38 -2.42% 454.98 452.17 0.62%
Expenses 6.04 6.32 -4.43% 342.57 319.50 7.22% 585.00 392.86 48.91% 410.27 409.98 0.07%
EBITDA -0.33 -0.59 - -61.89 39.80 - -154.30 48.51 - 44.71 42.19 5.97%
EBIDTM -4.98% -8.75% -18.19% 9.52% -31.42% 9.45% 8.86% 8.22%
Other Income 0.03 0.69 -95.65% 0.35 0.55 -36.36% 0.08 1.47 -94.56% 0.57 0.48 18.75%
Interest 0.00 0.00 0 18.70 19.98 -6.41% 17.67 24.16 -26.86% 17.12 24.84 -31.08%
Depreciation 0.20 0.45 -55.56% 16.52 15.46 6.86% 15.77 14.70 7.28% 15.61 15.37 1.56%
PBT -0.51 -0.35 - -96.76 4.92 - -187.67 11.12 - 12.55 2.46 410.16%
Tax -0.18 -0.12 - -33.52 1.95 - -57.58 10.52 - 4.71 0.89 429.21%
PAT -0.33 -0.23 - -63.23 2.97 - -130.09 0.60 - 7.84 1.56 402.56%
PATM -5.00% -3.39% -18.58% 0.71% -26.49% 0.12% 1.55% 0.30%
EPS -0.01 -0.01 - -2.82 0.13 - -5.80 0.03 - 0.35 0.07 400.00%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 5.71 5.73 -0.35% 280.67 359.30 -21.88% 430.69 441.38 -2.42% 454.98 452.17 0.62%
Expenses 6.04 6.32 -4.43% 342.57 319.50 7.22% 585.00 392.87 48.90% 410.27 409.98 0.07%
EBITDA -0.33 -0.59 - -61.89 39.80 - -154.30 48.50 - 44.71 42.19 5.97%
EBIDTM -4.98% -8.75% -18.19% 9.52% -31.42% 9.45% 8.86% 8.22%
Other Income 0.03 0.69 -95.65% 0.35 0.55 -36.36% 0.08 1.47 -94.56% 0.57 0.48 18.75%
Interest 0.00 0.00 0 18.70 19.98 -6.41% 17.67 24.16 -26.86% 17.12 24.84 -31.08%
Depreciation 0.20 0.45 -55.56% 16.52 15.46 6.86% 15.77 14.70 7.28% 15.61 15.37 1.56%
PBT -0.51 -0.35 - -96.76 4.92 - -187.67 11.11 - 12.55 2.46 410.16%
Tax -0.18 -0.12 - -33.52 1.95 - -57.58 10.52 - 4.71 0.89 429.21%
PAT -0.33 -0.23 - -63.23 2.97 - -130.09 0.59 - 7.84 1.56 402.56%
PATM -5.00% -3.39% -18.58% 0.71% -26.49% 0.12% 1.55% 0.30%
EPS -7.85 0.25 - -2.82 0.13 - -5.80 0.03 - 0.35 0.07 400.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,172.05 1,669.97 1,684.09 1,523.67 1,668.23 1,541.82 2,362.80 2,784.93 1,875.53 1,643.34 1,676.32 Net Sales Growth -6.88% -0.84% 10.53% -8.67% 8.20% -34.75% -15.16% 48.49% 14.13% -1.97% Cost Of Goods Sold 1,101.51 1,368.01 1,202.24 1,159.20 1,222.29 1,155.62 1,857.58 2,221.15 1,366.48 1,154.17 1,174.68 Gross Profit 70.54 301.96 481.84 364.47 445.94 386.21 505.22 563.78 509.05 489.17 501.64 GP Margin 6.02% 18.08% 28.61% 23.92% 26.73% 25.05% 21.38% 20.24% 27.14% 29.77% 29.93% Total Expenditure 1,343.88 1,699.53 1,532.53 1,468.95 1,509.42 1,440.26 2,144.83 2,521.03 1,639.49 1,419.13 1,437.49 Power & Fuel Cost - 104.16 129.52 127.39 101.41 84.63 92.72 103.47 91.85 75.44 87.89 % Of Sales - 6.24% 7.69% 8.36% 6.08% 5.49% 3.92% 3.72% 4.90% 4.59% 5.24% Employee Cost - 93.61 81.71 75.14 71.91 70.55 78.19 76.54 74.65 75.54 78.38 % Of Sales - 5.61% 4.85% 4.93% 4.31% 4.58% 3.31% 2.75% 3.98% 4.60% 4.68% Manufacturing Exp. - 60.05 56.12 45.32 45.56 44.64 46.88 50.38 52.90 53.32 39.56 % Of Sales - 3.60% 3.33% 2.97% 2.73% 2.90% 1.98% 1.81% 2.82% 3.24% 2.36% General & Admin Exp. - 23.78 21.57 19.29 18.32 20.73 19.94 21.77 23.02 20.05 20.34 % Of Sales - 1.42% 1.28% 1.27% 1.10% 1.34% 0.84% 0.78% 1.23% 1.22% 1.21% Selling & Distn. Exp. - 46.59 38.99 41.28 48.03 50.79 45.75 44.68 28.72 39.00 35.24 % Of Sales - 2.79% 2.32% 2.71% 2.88% 3.29% 1.94% 1.60% 1.53% 2.37% 2.10% Miscellaneous Exp. - 3.33 2.37 1.32 1.90 13.31 3.76 3.04 1.87 1.61 35.24 % Of Sales - 0.20% 0.14% 0.09% 0.11% 0.86% 0.16% 0.11% 0.10% 0.10% 0.08% EBITDA -171.81 -29.56 151.56 54.72 158.81 101.56 217.97 263.90 236.04 224.21 238.83 EBITDA Margin -14.66% -1.77% 9.00% 3.59% 9.52% 6.59% 9.23% 9.48% 12.59% 13.64% 14.25% Other Income 1.03 15.99 26.81 53.06 11.32 11.38 4.36 6.04 6.04 22.67 5.78 Interest 53.49 85.58 99.37 89.35 78.81 112.03 125.82 148.13 115.20 117.41 123.31 Depreciation 48.10 62.39 60.72 59.12 56.97 60.25 60.77 63.26 64.31 62.25 57.39 PBT -272.39 -161.53 18.28 -40.69 34.35 -59.34 35.74 58.55 62.57 67.21 63.91 Tax -86.57 -47.85 13.27 -18.24 9.03 -11.50 5.68 11.22 10.41 12.08 9.59 Tax Rate 31.78% 29.62% 72.59% 44.83% 26.29% 13.58% 15.89% 19.16% 16.64% 17.97% 15.01% PAT -185.81 -113.68 5.00 -22.46 25.32 -73.15 30.06 47.33 52.15 55.13 54.33 PAT before Minority Interest -185.81 -113.68 5.00 -22.46 25.32 -73.15 30.06 47.33 52.15 55.13 54.33 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -15.85% -6.81% 0.30% -1.47% 1.52% -4.74% 1.27% 1.70% 2.78% 3.35% 3.24% PAT Growth -3,892.04% - - - - - -36.49% -9.24% -5.41% 1.47% EPS -8.28 -5.07 0.22 -1.00 1.13 -3.26 1.34 2.11 2.33 2.46 2.42

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,172.05 1,669.97 1,684.09 1,523.67 1,668.83 1,543.30 2,366.38 2,782.86 1,876.26 1,643.70 1,675.69 Net Sales Growth -6.88% -0.84% 10.53% -8.70% 8.13% -34.78% -14.97% 48.32% 14.15% -1.91% Cost Of Goods Sold 1,101.51 1,368.01 1,202.24 1,159.29 1,223.13 1,157.12 1,858.61 2,217.71 1,367.01 1,154.31 1,174.12 Gross Profit 70.54 301.96 481.85 364.38 445.70 386.19 507.77 565.16 509.25 489.39 501.57 GP Margin 6.02% 18.08% 28.61% 23.91% 26.71% 25.02% 21.46% 20.31% 27.14% 29.77% 29.93% Total Expenditure 1,343.88 1,699.53 1,532.53 1,470.66 1,510.29 1,441.84 2,146.68 2,518.70 1,640.10 1,419.29 1,436.94 Power & Fuel Cost - 104.16 129.52 127.39 101.41 84.63 92.72 103.47 91.85 75.44 87.89 % Of Sales - 6.24% 7.69% 8.36% 6.08% 5.48% 3.92% 3.72% 4.90% 4.59% 5.25% Employee Cost - 93.61 81.71 75.14 71.91 70.59 78.19 76.55 74.65 75.54 78.38 % Of Sales - 5.61% 4.85% 4.93% 4.31% 4.57% 3.30% 2.75% 3.98% 4.60% 4.68% Manufacturing Exp. - 60.05 56.12 45.32 45.56 44.64 46.88 50.38 52.90 53.32 39.56 % Of Sales - 3.60% 3.33% 2.97% 2.73% 2.89% 1.98% 1.81% 2.82% 3.24% 2.36% General & Admin Exp. - 23.78 21.58 19.34 18.36 20.74 20.15 21.82 23.02 20.07 20.36 % Of Sales - 1.42% 1.28% 1.27% 1.10% 1.34% 0.85% 0.78% 1.23% 1.22% 1.22% Selling & Distn. Exp. - 46.59 38.99 42.87 48.03 50.82 46.37 45.66 28.72 39.00 35.24 % Of Sales - 2.79% 2.32% 2.81% 2.88% 3.29% 1.96% 1.64% 1.53% 2.37% 2.10% Miscellaneous Exp. - 3.33 2.37 1.32 1.90 13.31 3.76 3.12 1.95 1.61 35.24 % Of Sales - 0.20% 0.14% 0.09% 0.11% 0.86% 0.16% 0.11% 0.10% 0.10% 0.08% EBITDA -171.81 -29.56 151.56 53.01 158.54 101.46 219.70 264.16 236.16 224.41 238.75 EBITDA Margin -14.66% -1.77% 9.00% 3.48% 9.50% 6.57% 9.28% 9.49% 12.59% 13.65% 14.25% Other Income 1.03 7.47 17.06 53.06 11.32 11.38 4.36 6.04 6.04 22.67 5.78 Interest 53.49 77.05 89.62 89.36 78.81 112.03 125.83 148.13 115.20 117.41 123.31 Depreciation 48.10 62.39 60.72 59.12 56.97 60.25 60.77 63.26 64.31 62.25 57.39 PBT -272.39 -161.53 18.27 -42.42 34.08 -59.45 37.47 58.82 62.68 67.42 63.83 Tax -86.57 -47.85 13.27 -18.24 9.03 -11.50 5.68 11.22 10.41 12.08 9.59 Tax Rate 31.78% 29.62% 72.63% 43.00% 26.50% 13.57% 15.16% 19.08% 16.61% 17.92% 15.02% PAT -185.81 -113.68 5.00 -24.18 25.05 -73.26 31.79 47.60 52.27 55.34 54.24 PAT before Minority Interest -185.81 -113.68 5.00 -24.18 25.05 -73.26 31.79 47.60 52.27 55.34 54.24 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -15.85% -6.81% 0.30% -1.59% 1.50% -4.75% 1.34% 1.71% 2.79% 3.37% 3.24% PAT Growth -3,899.80% - - - - - -33.21% -8.93% -5.55% 2.03% EPS -8.28 -5.07 0.22 -1.08 1.12 -3.27 1.42 2.12 2.33 2.47 2.42

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 956.11 1,069.25 1,064.59 1,086.86 1,060.73 1,134.61 1,104.64 1,058.63 1,006.73 954.27 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 933.69 1,046.83 1,042.17 1,064.44 1,038.31 1,112.18 1,082.21 1,036.20 984.30 931.85 Non-Current Liabilities 14.54 141.51 213.12 296.66 126.79 249.67 299.91 355.94 295.66 362.35 Secured Loans 47.13 127.31 213.16 280.80 127.46 120.00 164.40 218.21 161.20 243.44 Unsecured Loans 13.00 13.00 13.31 10.28 0.78 1.48 1.19 1.87 2.60 1.96 Long Term Provisions 8.73 7.94 6.45 6.39 7.74 8.20 9.36 9.07 8.49 6.91 Current Liabilities 1,021.54 972.82 890.93 1,003.75 1,187.39 1,247.89 1,299.23 1,309.32 1,278.66 1,239.95 Trade Payables 438.12 419.66 318.75 376.65 342.15 527.14 483.00 539.42 528.10 496.78 Other Current Liabilities 140.29 138.72 111.40 122.63 131.63 95.44 170.40 123.40 106.88 107.95 Short Term Borrowings 440.21 412.22 458.91 502.77 712.00 619.71 635.97 634.08 630.34 627.24 Short Term Provisions 2.92 2.22 1.86 1.70 1.61 5.59 9.87 12.41 13.34 7.98 Total Liabilities 1,992.19 2,183.58 2,168.64 2,387.27 2,374.91 2,632.17 2,703.78 2,723.89 2,581.05 2,556.57 Net Block 633.11 642.71 661.97 723.10 771.89 784.85 824.82 852.35 881.24 905.58 Gross Block 1,652.17 1,599.41 1,557.96 1,562.95 1,555.70 1,508.82 1,490.49 1,456.36 1,363.67 1,383.66 Accumulated Depreciation 1,019.06 956.71 895.99 839.85 783.81 723.97 665.68 604.00 482.43 478.08 Non Current Assets 754.60 899.75 937.47 1,033.52 1,137.34 1,018.49 1,036.29 1,063.54 1,085.38 1,092.25 Capital Work in Progress 56.73 65.75 77.78 85.10 98.63 115.00 99.55 99.79 102.11 99.35 Non Current Investment 0.24 0.24 0.24 0.57 0.57 0.57 0.60 0.60 0.60 0.60 Long Term Loans & Adv. 13.41 12.62 10.93 9.76 12.17 115.07 108.33 104.19 96.90 82.24 Other Non Current Assets 51.11 178.44 186.54 214.99 254.08 2.99 2.99 6.61 4.53 4.47 Current Assets 1,237.59 1,283.83 1,231.17 1,353.75 1,237.57 1,613.68 1,667.49 1,660.35 1,495.67 1,464.33 Current Investments 0.53 0.50 0.32 0.46 0.46 0.17 0.51 0.51 0.41 0.52 Inventories 690.16 709.15 672.60 659.77 586.97 975.13 914.53 859.43 854.13 836.06 Sundry Debtors 345.49 379.19 279.61 446.98 374.59 396.87 561.38 612.12 500.43 492.24 Cash & Bank 19.22 19.80 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41 Other Current Assets 182.19 42.31 96.05 67.05 250.12 220.28 170.50 179.38 127.89 99.09 Short Term Loans & Adv. 136.22 132.88 165.03 161.75 198.45 149.76 98.69 124.56 74.01 67.55 Net Current Assets 216.04 311.01 340.25 350.00 50.17 365.79 368.26 351.03 217.01 224.38 Total Assets 1,992.19 2,183.58 2,168.64 2,387.27 2,374.91 2,632.17 2,703.78 2,723.89 2,581.05 2,556.58

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 956.11 1,069.25 1,064.59 1,087.90 1,062.03 1,136.13 1,105.16 1,058.66 1,006.68 954.08 Share Capital 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 22.43 Total Reserves 933.68 1,046.82 1,042.17 1,065.48 1,039.60 1,113.70 1,082.73 1,036.23 984.25 931.65 Non-Current Liabilities 14.54 141.51 213.12 296.29 126.41 249.29 299.92 355.84 295.58 362.30 Secured Loans 47.13 127.31 213.16 280.80 127.46 120.00 164.40 218.21 161.20 243.44 Unsecured Loans 13.00 13.00 13.31 10.28 0.78 1.48 1.19 1.87 2.60 1.96 Long Term Provisions 8.73 7.94 6.45 6.39 7.74 8.20 9.36 9.07 8.49 6.91 Current Liabilities 1,021.54 972.82 890.93 1,003.83 1,187.39 1,247.89 1,299.91 1,309.32 1,278.66 1,239.95 Trade Payables 438.12 419.66 318.75 376.65 342.15 527.14 483.67 539.42 528.10 496.78 Other Current Liabilities 140.29 138.72 111.40 122.71 131.63 95.44 170.40 123.40 106.88 107.95 Short Term Borrowings 440.21 412.22 458.91 502.77 712.00 619.71 635.97 634.08 630.34 627.24 Short Term Provisions 2.92 2.22 1.86 1.70 1.61 5.59 9.87 12.41 13.34 7.98 Total Liabilities 1,992.19 2,183.58 2,168.64 2,388.02 2,375.83 2,633.31 2,704.99 2,723.82 2,580.92 2,556.33 Net Block 633.11 642.71 661.97 723.10 771.89 784.85 824.82 852.35 881.24 905.58 Gross Block 1,652.17 1,599.41 1,557.96 1,562.95 1,555.70 1,508.82 1,490.49 1,456.36 1,363.67 1,383.66 Accumulated Depreciation 1,019.06 956.71 895.99 839.85 783.81 723.97 665.68 604.00 482.43 478.08 Non Current Assets 754.60 899.75 937.46 1,033.18 1,137.01 1,018.15 1,035.96 1,063.21 1,085.05 1,091.92 Capital Work in Progress 56.73 65.75 77.78 85.10 98.63 115.00 99.55 99.79 102.11 99.35 Non Current Investment 0.24 0.24 0.24 0.24 0.24 0.24 0.27 0.27 0.27 0.27 Long Term Loans & Adv. 13.41 12.62 10.93 9.76 12.17 115.07 108.33 104.19 96.90 82.24 Other Non Current Assets 51.11 178.44 186.54 214.99 254.08 2.99 2.99 6.61 4.53 4.47 Current Assets 1,237.59 1,283.83 1,231.18 1,354.85 1,238.83 1,615.16 1,669.03 1,660.61 1,495.86 1,464.42 Current Investments 0.53 0.50 0.32 0.46 0.46 0.17 0.51 0.51 0.41 0.52 Inventories 690.16 709.15 672.60 659.86 587.89 977.55 917.97 859.43 854.65 836.71 Sundry Debtors 345.49 379.19 279.61 446.98 374.83 395.87 558.73 611.97 499.73 491.45 Cash & Bank 19.22 19.81 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65 Other Current Assets 182.19 42.31 96.05 67.05 250.12 220.28 170.50 179.38 127.89 99.09 Short Term Loans & Adv. 136.22 132.88 165.03 162.69 198.45 149.76 98.69 124.56 74.01 67.55 Net Current Assets 216.05 311.01 340.26 351.02 51.44 367.27 369.13 351.29 217.20 224.47 Total Assets 1,992.19 2,183.58 2,168.64 2,388.03 2,375.84 2,633.31 2,704.99 2,723.82 2,580.91 2,556.34

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 169.44 224.69 133.37 95.04 21.33 285.65 238.89 65.14 198.62 168.91 PBT -161.53 18.28 -40.69 34.35 -84.65 35.74 58.55 62.57 67.21 64.83 Adjustment 139.02 137.55 97.08 125.44 148.28 187.58 206.90 175.74 158.85 174.16 Changes in Working Capital 191.95 68.87 76.98 -64.75 -38.69 71.65 -13.00 -160.56 -20.26 -61.52 Cash after chg. in Working capital 169.44 224.69 133.37 95.04 24.94 294.98 252.45 77.75 205.80 177.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 -3.61 -9.33 -13.56 -12.62 -7.17 -8.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -41.93 -17.02 52.03 16.64 -28.62 -33.13 -26.13 -29.43 -18.10 -77.21 Net Fixed Assets -43.74 -29.42 12.31 6.28 -30.51 -33.78 -33.89 -90.37 17.23 59.72 Net Investments -0.03 -0.18 0.47 0.00 -0.29 0.37 0.00 -0.10 0.11 -0.53 Others 1.84 12.58 39.25 10.36 2.18 0.28 7.76 61.04 -35.44 -136.40 Cash from Financing Activity -128.09 -205.44 -185.57 -119.38 11.49 -251.87 -201.09 -39.60 -204.12 -88.68 Net Cash Inflow / Outflow -0.58 2.23 -0.17 -7.70 4.20 0.65 11.67 -3.90 -23.60 3.03 Opening Cash & Equivalents 19.80 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41 33.38 Closing Cash & Equivalent 19.22 19.80 17.57 17.74 25.43 21.23 20.58 8.91 12.81 36.41

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 169.44 224.69 133.65 95.00 21.38 284.96 239.24 65.17 198.76 168.82 PBT -161.53 18.27 -42.42 34.08 -84.77 37.47 58.82 62.68 67.42 64.74 Adjustment 139.02 137.55 98.14 125.47 150.40 186.46 207.17 175.82 158.85 174.16 Changes in Working Capital 191.95 68.87 77.93 -64.54 -40.54 70.36 -13.19 -160.72 -20.34 -61.52 Cash after chg. in Working capital 169.44 224.69 133.65 95.00 25.09 294.29 252.79 77.79 205.93 177.38 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 -3.71 -9.33 -13.56 -12.62 -7.17 -8.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -41.93 -17.02 51.70 16.64 -28.62 -33.13 -26.13 -29.43 -18.10 -76.88 Net Fixed Assets -43.74 -29.42 12.31 6.28 -30.51 -33.78 -33.89 -90.37 17.23 59.72 Net Investments -0.03 -0.18 0.47 0.00 -0.29 0.37 0.00 -0.10 0.11 -0.53 Others 1.84 12.58 38.92 10.36 2.18 0.28 7.76 61.04 -35.44 -136.07 Cash from Financing Activity -128.09 -205.44 -185.58 -119.38 11.49 -251.87 -201.09 -39.60 -204.12 -88.68 Net Cash Inflow / Outflow -0.58 2.23 -0.23 -7.73 4.25 -0.03 12.02 -3.87 -23.47 3.27 Opening Cash & Equivalents 19.81 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65 33.38 Closing Cash & Equivalent 19.22 19.81 17.58 17.81 25.54 21.29 21.33 9.31 13.18 36.65

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 42.63 47.68 47.47 48.46 47.30 50.59 49.26 47.21 44.89 42.55 ROA -5.44% 0.23% -0.99% 1.06% -2.92% 1.13% 1.74% 1.97% 2.15% 2.14% ROE -11.23% 0.47% -2.09% 2.36% -6.66% 2.68% 4.38% 5.05% 5.62% 5.79% ROCE -4.68% 6.68% 2.58% 5.79% 1.41% 8.24% 10.28% 9.12% 9.71% 9.95% Fixed Asset Turnover 1.17 1.22 1.12 1.23 1.15 1.76 2.11 1.48 1.27 1.27 Receivable days 69.30 62.43 75.92 77.89 79.89 66.26 68.75 97.04 103.90 95.54 Inventory Days 133.82 130.94 139.22 118.20 161.77 130.67 103.93 149.46 176.91 165.59 Payable days 114.43 112.09 109.48 107.32 137.28 82.41 68.82 113.92 128.03 119.13 Cash Conversion Cycle 88.68 81.28 105.66 88.77 104.38 114.51 103.87 132.58 152.78 141.99 Total Debt/Equity 0.61 0.59 0.71 0.79 0.85 0.69 0.82 0.90 0.87 1.01 Interest Cover -0.89 1.18 0.54 1.44 0.24 1.28 1.40 1.54 1.57 1.52

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 42.63 47.68 47.47 48.51 47.36 50.66 49.28 47.21 44.89 42.54 ROA -5.44% 0.23% -1.06% 1.05% -2.93% 1.19% 1.75% 1.97% 2.15% 2.14% ROE -11.23% 0.47% -2.25% 2.33% -6.67% 2.84% 4.40% 5.06% 5.64% 5.78% ROCE -5.21% 6.12% 2.49% 5.77% 1.41% 8.32% 10.29% 9.13% 9.73% 9.95% Fixed Asset Turnover 1.17 1.22 1.12 1.23 1.15 1.76 2.11 1.48 1.27 1.26 Receivable days 69.30 62.43 75.92 77.89 79.75 65.92 68.64 96.93 103.72 95.49 Inventory Days 133.82 130.94 139.23 118.26 161.98 130.89 104.21 149.46 176.99 165.71 Payable days 114.43 112.09 109.47 107.25 137.11 82.45 68.84 113.92 128.03 119.13 Cash Conversion Cycle 88.68 81.28 105.68 88.90 104.62 114.37 104.01 132.47 152.69 142.07 Total Debt/Equity 0.61 0.59 0.71 0.79 0.85 0.69 0.82 0.90 0.87 1.01 Interest Cover -1.10 1.20 0.53 1.43 0.24 1.30 1.40 1.54 1.57 1.52

Top Investors:

Annual Reports:

News Update:

Nectar Lifesciences to sell business of Empty Hard Gelatin Capsule unit
22nd Dec 2025, 11:29 AM

The company has executed the Business Transfer agreement with Capnest Health Care
Read More
Nectar Lifesciences completes sale of API and formulations business
12th Nov 2025, 11:43 AM

The transfer is completed with effect from November 10, 2025
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback